SEC Form 4 · accession 0001127602-19-006972
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig C. Hopkinson
Officer — SVP, Med Dev/Med Affairs, CMO
Period of report
Feb 16, 2019
Accepted (ET)
Feb 19, 2019 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 16, 2019 | M | 3,375 | $0.00 | A | 7,078 | D | |
| Ordinary Shares | Feb 16, 2019 | F | 1,083 | $32.54 | D | 5,995 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit AwardF1 | $0.00 | Feb 16, 2019 | M | 3,375 | D | Feb 16, 2019 | — | Ordinary Shares | 3,375 | 10,125 | D |
Explanation of responses
- F1Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19.